Implementing thrombosis guidelines in cancer patients: a review

Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as the need for adequate prevention and treatmen...

Full description

Saved in:
Bibliographic Details
Published in:Rambam Maimonides medical journal 2014-10, Vol.5 (4), p.e0041-e0041
Main Authors: Farge-Bancel, Dominique, Bounameaux, Henri, Brenner, Benjamin, Büller, Harry R, Kakkar, Ajay, Pabinger, Ingrid, Streiff, Michael, Debourdeau, Philippe
Format: Article
Language:English
Subjects:
Anticoagulants
cancer
Current Clinical Practice
guidelines
thrombosis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Venous thromboembolism is a frequent and serious complication in patients with cancer. It is an independent prognostic factor of death in cancer patients and the second leading cause of death, but physicians often underestimate its importance, as well as the need for adequate prevention and treatment. Management of venous thromboembolism in patients with cancer requires the coordinated efforts of a wide range of clinicians, highlighting the importance of a multidisciplinary approach. However, a lack of consensus among various national and international clinical practice guidelines has contributed to knowledge and practice gaps among practitioners, and inconsistent approaches to venous thromboembolism. The 2013 international guidelines for thrombosis in cancer have sought to address these gaps by critically re-evaluating the evidence coming from clinical trials and synthesizing a number of guidelines documents. An individualized approach to prophylaxis is recommended for all patients.
ISSN:2076-9172
2076-9172
DOI:10.5041/RMMJ.10175